Dashboard
Manage Tickers

TRML


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
HC Wainwright & Co. Reiterates Buy on Tour...
08/12/2024 11:31:00

HC Wainwright & Co. analyst Yi Chen reiterates Tourmaline Bio (NASDAQ:TRML) with a Buy and maintains $48 price target.

Core News & Articles
Tourmaline Bio Q2 2024 Adj EPS $(0.68) Bea...
08/08/2024 12:51:11

Tourmaline Bio (NASDAQ:TRML) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(0.71...

Core News & Articles
Tourmaline Bio Presents Phase 2 TRANQUILIT...
08/02/2024 20:31:17

Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability,...

Core News & Articles
Tourmaline Bio Names Ryan Robinson As CFO,...
06/27/2024 12:06:10

Core News & Articles
HC Wainwright & Co. Reiterates Buy on Tour...
05/14/2024 13:57:43

HC Wainwright & Co. analyst Yi Chen reiterates Tourmaline Bio (NASDAQ:TRML) with a Buy and maintains $48 price target.

Core News & Articles
Tourmaline Bio Ended The First Quarter Wit...
05/13/2024 11:19:20

Core News & Articles
Tourmaline Bio Q1 2024 GAAP EPS $(0.55) Be...
05/13/2024 11:18:29

Core News & Articles
Truist Securities Reiterates Buy on Tourma...
03/25/2024 16:27:18

Truist Securities analyst Robyn Karnauskas reiterates Tourmaline Bio (NASDAQ:TRML) with a Buy and maintains $74 price target.

why-factset-research-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why FactSet Research Shares Are Trading Lo...
03/21/2024 18:39:11

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-th...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 17:31:11

dow-jumps-200-points-us-weekly-jobless-claims-fall
Dow Jumps 200 Points; US Weekly Jobless Cl...
03/21/2024 13:47:49

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market o...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 13:05:49

five-below-posts-q4-results-joins-lexinfintech-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Five Below Posts Q4 Results, Joins LexinFi...
03/21/2024 10:15:31

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Thursday.

Core News & Articles
HC Wainwright & Co. Reiterates Buy on Tour...
03/20/2024 10:46:31

HC Wainwright & Co. analyst Yi Chen reiterates Tourmaline Bio (NASDAQ:TRML) with a Buy and maintains $48 price target.

Core News & Articles
Tourmaline Bio Q4 EPS $(0.81) Up From $(5....
03/19/2024 11:07:57

Tourmaline Bio (NASDAQ:TRML) reported quarterly losses of $(0.81) per share. This is a 85.3 percent increase over losses of $(5...

Core News & Articles
Tourmaline Bio Reports Pricing Of Public O...
01/25/2024 12:11:53

The gross proceeds to Tourmaline from the offering, before deducting underwriting discounts and commissions and offering expens...

Core News & Articles
Tourmaline Bio Announces Proposed Public O...
01/24/2024 21:34:23

Tourmaline Bio, Inc. ("Tourmaline") (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformativ...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
01/24/2024 21:31:07

Core News & Articles
Tourmaline Bio Announces Expected Upcoming...
01/08/2024 12:20:22

Tourmaline plans to accelerate the initiation of a pivotal Phase 3 trial in 2024 evaluating subcutaneous TOUR006 every 8 week...

tdcx-receives-preliminary-non-binding-proposal-letter-joins-pure-storage-dyne-therapeutics-and-other-big-stocks-moving-higher-on-wednesday
TDCX Receives Preliminary Non-binding Prop...
01/03/2024 15:24:25

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) r...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION